Proposed withdrawal of bipolar disorder treatment revoked

The manufacturer of first-line bipolar disorder treatment Priadel (lithium carbonate) has agreed to continue supplying the NHS with the drug, after negotiating new prices with the Department of Health and Social Care (DHSC).

by Sandhiya Sodha
Lithium is recommended by NICE as a first-line treatment for bipolar disorder. It's estimated that one in a hundred people have bipolar disorder and one in five of these take lithium. | GETTY IMAGES
Lithium is recommended by NICE as a first-line treatment for bipolar disorder. It's estimated that one in a hundred people have bipolar disorder and one in five of these take lithium. | GETTY IMAGES

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package